Italy's accidental CBD liberalization led to significant drops in prescriptions for anxiety, sleep, pain, and psychiatric medications
When light cannabis (CBD products) became unexpectedly available in Italy in 2017, prescription sales of anxiolytics, sedatives, opioids, antidepressants, and antipsychotics significantly declined.
Quick Facts
What This Study Found
Using the staggered rollout of light cannabis shops across Italian provinces, the study documented significant substitution effects between CBD products and five prescription drug categories: anxiolytics, sedatives, opioids, antidepressants, and antipsychotics.
Key Numbers
Significant substitution effects documented for five drug categories: anxiolytics, sedatives, opioids, antidepressants, and antipsychotics. The study used high-frequency data across all Italian provinces.
How They Did This
Natural experiment exploiting Italy's unintended 2017 liberalization of CBD-based "light cannabis." High-frequency prescription drug sales data analyzed using the staggered local availability of light cannabis across Italian provinces as a quasi-experimental design.
Why This Research Matters
This provides some of the strongest economic evidence that legal access to CBD products leads people to substitute away from prescription medications, with implications for drug policy and healthcare costs.
The Bigger Picture
The pattern of prescription substitution suggests people may be self-treating symptoms of anxiety, pain, sleep disorders, and mood conditions with CBD products, whether or not clinical evidence supports those uses.
What This Study Doesn't Tell Us
Cannot identify individual-level substitution; ecological design using province-level data; cannot determine whether patients benefited from switching to CBD; unregulated CBD products may have variable quality.
Questions This Raises
- ?Are patients who switched to CBD experiencing better or worse outcomes?
- ?Could regulated CBD access reduce healthcare costs if substitution effects are confirmed?
Trust & Context
- Key Stat:
- CBD availability reduced prescriptions across five drug categories including opioids
- Evidence Grade:
- Clever natural experiment design using staggered rollout, but ecological data cannot confirm individual-level substitution or health outcomes.
- Study Age:
- Published in 2020.
- Original Title:
- Do-It-Yourself medicine? The impact of light cannabis liberalization on prescription drugs.
- Published In:
- Journal of health economics, 74, 102371 (2020)
- Authors:
- Carrieri, Vincenzo, Madio, Leonardo, Principe, Francesco
- Database ID:
- RTHC-02454
Evidence Hierarchy
Watches what happens naturally without intervening.
What do these levels mean? →Frequently Asked Questions
What is "light cannabis" in Italy?
In 2017, a regulatory gray area allowed the sale of CBD-based cannabis products with negligible THC levels in Italy. This created an unintended natural experiment that researchers used to study the effect of CBD availability on prescription drug use.
Does this mean CBD is as effective as prescription medications?
The study shows people substituted CBD for prescriptions, but it cannot determine whether they experienced equivalent symptom relief. Some patients may have benefited, while others may have received less effective treatment.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-02454APA
Carrieri, Vincenzo; Madio, Leonardo; Principe, Francesco. (2020). Do-It-Yourself medicine? The impact of light cannabis liberalization on prescription drugs.. Journal of health economics, 74, 102371. https://doi.org/10.1016/j.jhealeco.2020.102371
MLA
Carrieri, Vincenzo, et al. "Do-It-Yourself medicine? The impact of light cannabis liberalization on prescription drugs.." Journal of health economics, 2020. https://doi.org/10.1016/j.jhealeco.2020.102371
RethinkTHC
RethinkTHC Research Database. "Do-It-Yourself medicine? The impact of light cannabis libera..." RTHC-02454. Retrieved from https://rethinkthc.com/research/carrieri-2020-doityourself-medicine-the-impact
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.